BRCA1 antibody (pSer1189)
Quick Overview for BRCA1 antibody (pSer1189) (ABIN127308)
Target
See all BRCA1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pSer1189
-
Specificity
- Detect BRCA1 when phosphorylated at Ser1189.
-
Purification
- Peptide affinity purified
-
Immunogen
- Phosphorylated synthetic peptide surrounding Serine 1189 of human BRCA1.
-
-
-
-
Application Notes
-
Western Blot: 1-2 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- PBS pH 7.2, containing 50 % glycerol, 1 % BSA, 0.02 % thimerosal
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C/-80 °C
-
Storage Comment
- Store the antibody undiluted at -20 °C or for long term storage (in aliquots) at -70 °C.
-
-
- BRCA1 (Breast Cancer 1 (BRCA1))
-
Alternative Name
- BRCA1 / RNF53
-
Background
- BRCA1 is a breast cancer susceptibility gene that was localized to chromosome 17q. Mutations within this gene are believed to account for approximately 45 % of families with high incidence of breast cancer and at least 80 % of families with increased incidence of both earlyonset breast cancer and ovarian cancer. The BRCA1 gene is expressed in numerous tissues, including breast and ovary, and encodes a predicted protein of 1863 amino acids. Like many other genes involved in familial cancer, BRCA1 appears to encode a tumor suppressor, a protein that acts as a negative regulator of tumor growth.Synonyms: Breast cancer type 1 susceptibility protein, RING finger protein 53
-
Gene ID
- 672
-
NCBI Accession
- NP_009225
-
UniProt
- P38398
-
Pathways
- Cell Division Cycle, DNA Damage Repair, Intracellular Steroid Hormone Receptor Signaling Pathway, Positive Regulation of Response to DNA Damage Stimulus
Target
-